Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia

相似書籍

• Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01
  由: Loh, Mignon L., et al.
  出版: (2006)
• Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000)
  由: Silverman, Lewis B., et al.
  出版: (2009)
• The Low Incidence of Secondary Acute Myelogenous Leukemia in Children and Adolescents Treated with Dexrazoxane for Acute Lymphoblastic Leukemia: A Report from the Dana-Farber Cancer Institute ALL Consortium
  由: Vrooman, Lynda M., et al.
  出版: (2011)
• Neuropsychological Outcomes of Standard Risk and High Risk Patients Treated for Acute Lymphoblastic Leukemia on Dana-Farber ALL Consortium Protocol 95-01 at 5 Years Post Diagnosis
  由: Waber, Deborah P., et al.
  出版: (2011)
• Postinduction Dexamethasone and Individualized Dosing of Escherichia Coli L-Asparaginase Each Improve Outcome of Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia: Results From a Randomized Study—Dana-Farber Cancer Institute ALL Consortium Protocol 00-01
  由: Vrooman, Lynda M., et al.
  出版: (2013)